Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of
B B McConnell1, F J Gregory, F J Stott
1Imperial Cancer Research Fund Laboratories, London WC2A 3PX, United Kingdom.
Abstract:
To investigate the mode of action of the p16(INK4a) tumor suppressor protein, we have established U2-OS cells in which the expression of p16(INK4a) can be regulated by addition or removal of isopropyl-beta-D-thiogalactopyranoside. As expected, induction of p16(INK4a) results in a G1 cell cycle arrest by inhibiting phosphorylation of the retinoblastoma protein (pRb) by the cyclin-dependent kinases CDK4 and CDK6. However, induction of p16(INK4a) also causes marked inhibition of CDK2 activity. In the case of cyclin E-CDK2, this is brought about by reassortment of cyclin, CDK, and CDK-inhibitor complexes, particularly those involving p27(KIP1). Size fractionation of the cellular lysates reveals that a substantial proportion of CDK4 participates in active kinase complexes of around 200 kDa. Upon induction of p16(INK4a), this complex is partly dissociated, and the majority of CDK4 is found in lower-molecular-weight fractions consistent with the formation of a binary complex with p16(INK4a). Sequestration of CDK4 by p16(INK4a) allows cyclin D1 to associate increasingly with CDK2, without affecting its interactions with the CIP/KIP inhibitors. Thus, upon the induction of p16(INK4a), p27(KIP1) appears to switch its allegiance from CDK4 to CDK2, and the accompanying reassortment of components leads to the inhibition of cyclin E-CDK2 by p27(KIP1) and p21(CIP1). Significantly, p16(INK4a) itself does not appear to form higher-order complexes, and the overwhelming majority remains either free or forms binary associations with CDK4 and CDK6.
Insights
The p16(INK4a) tumor suppressor protein arrests the cell cycle by inhibiting cyclin-dependent kinases (CDKs). It sequesters CDK4, leading to p27(KIP1) inhibiting CDK2, thus halting cell proliferation.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- p16(INK4a) is a crucial tumor suppressor protein involved in cell cycle control.
- Its precise mechanism of action, particularly regarding CDK inhibition, requires further elucidation.
Purpose of the Study:
- To investigate the detailed mechanism of action of the p16(INK4a) tumor suppressor protein.
- To understand how p16(INK4a) influences cell cycle arrest by modulating CDK activity and complex formation.
Main Methods:
- Utilized U2-OS cells with inducible p16(INK4a) expression.
- Performed cell cycle analysis, kinase activity assays, and size fractionation of cellular lysates.
Main Results:
- p16(INK4a) induction caused G1 cell cycle arrest by inhibiting retinoblastoma protein (pRb) phosphorylation via CDK4/CDK6.
- p16(INK4a) also inhibited CDK2 activity through complex reassortment, with p27(KIP1) shifting from CDK4 to CDK2.
- CDK4 sequestration by p16(INK4a) facilitated cyclin D1 association with CDK2.
Conclusions:
- p16(INK4a) acts by sequestering CDK4, indirectly inhibiting CDK2 activity and causing cell cycle arrest.
- This reassortment of cell cycle regulatory proteins, including p27(KIP1) and p21(CIP1), is critical for p16(INK4a)'s tumor suppressive function.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

